Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "http://hemonc.org" to "https://hemonc.org") |
||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Corticosteroid, glucocorticoid.<ref name="insert">[http://www.merzusa.com/pdf/Sterapred_pi.pdf Prednisone (Sterapred) package insert]</ref><ref>[ | + | Class/mechanism: Corticosteroid, glucocorticoid.<ref name="insert">[http://www.merzusa.com/pdf/Sterapred_pi.pdf Prednisone (Sterapred) package insert]</ref><ref>[https://hemonc.org/docs/packageinsert/prednisone.pdf Prednisone (Sterapred) package insert (locally hosted backup)]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| Line 8: | Line 8: | ||
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | ||
| − | ==Diseases for which it is established== | + | ==Diseases for which it is established ''(work in progress)''== |
*[[B-cell acute lymphoblastic leukemia]] | *[[B-cell acute lymphoblastic leukemia]] | ||
**[[B-cell acute lymphoblastic leukemia, Ph-positive, pediatric]] | **[[B-cell acute lymphoblastic leukemia, Ph-positive, pediatric]] | ||
| − | *[[Hodgkin lymphoma]] | + | *[[Classical Hodgkin lymphoma]] |
*[[Langerhans cell histiocytosis]] | *[[Langerhans cell histiocytosis]] | ||
| + | *[[Multiple myeloma]] | ||
*Non-Hodgkin lymphoma | *Non-Hodgkin lymphoma | ||
**[[Adult T-cell leukemia-lymphoma]] | **[[Adult T-cell leukemia-lymphoma]] | ||
| Line 22: | Line 23: | ||
**[[Mantle cell lymphoma]] | **[[Mantle cell lymphoma]] | ||
**[[Marginal zone lymphoma]] | **[[Marginal zone lymphoma]] | ||
| + | **[[Non-Hodgkin lymphoma, pediatric]] | ||
**[[Peripheral T-cell lymphoma]] | **[[Peripheral T-cell lymphoma]] | ||
| + | **[[Primary mediastinal B-cell lymphoma]] | ||
| + | **[[Waldenström macroglobulinemia]] | ||
| + | *[[Prostate cancer]] | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3"> | <div style="column-count:3;-moz-column-count:3;-webkit-column-count:3"> | ||
| − | *[[Acquired | + | *[[Acquired hemophilia A]] |
*[[B-cell lymphoma of mucosa-associated lymphoid tissue]] | *[[B-cell lymphoma of mucosa-associated lymphoid tissue]] | ||
*[[Chronic lymphocytic leukemia]] | *[[Chronic lymphocytic leukemia]] | ||
| Line 35: | Line 40: | ||
*[[Large granular lymphocytic leukemia]] | *[[Large granular lymphocytic leukemia]] | ||
*[[Mediastinal gray-zone lymphoma]] | *[[Mediastinal gray-zone lymphoma]] | ||
| − | |||
| − | |||
*[[Myelofibrosis]] | *[[Myelofibrosis]] | ||
| − | |||
*[[Post-transplant lymphoproliferative disorder]] | *[[Post-transplant lymphoproliferative disorder]] | ||
| − | |||
| − | |||
*[[Smoldering multiple myeloma]] | *[[Smoldering multiple myeloma]] | ||
*[[T-cell acute lymphoblastic leukemia]] | *[[T-cell acute lymphoblastic leukemia]] | ||
*[[Thymoma]] | *[[Thymoma]] | ||
*[[Transformed lymphoma]] | *[[Transformed lymphoma]] | ||
| − | *[[ | + | *[[Warm autoimmune hemolytic anemia]] |
</div> | </div> | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
*[[Breast cancer - historical|Breast cancer]] | *[[Breast cancer - historical|Breast cancer]] | ||
| − | *[[Chronic | + | *[[Chronic myeloid leukemia - historical|Chronic myeloid leukemia]] |
*[[Light-chain (AL) amyloidosis - historical|Light-chain (AL) amyloidosis]] | *[[Light-chain (AL) amyloidosis - historical|Light-chain (AL) amyloidosis]] | ||
*[[Medulloblastoma - historical|Medulloblastoma]] | *[[Medulloblastoma - historical|Medulloblastoma]] | ||
| Line 58: | Line 58: | ||
*[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]</ref> | ||
| + | ==History of changes in EMA indication== | ||
| + | *1955-05-18: EURD | ||
==Also known as== | ==Also known as== | ||
*'''Generic names:''' pred | *'''Generic names:''' pred | ||
| Line 178: | Line 180: | ||
[[Category:Burkitt lymphoma medications]] | [[Category:Burkitt lymphoma medications]] | ||
[[Category:Chronic lymphocytic leukemia medications]] | [[Category:Chronic lymphocytic leukemia medications]] | ||
| − | [[Category:Acquired | + | [[Category:Acquired hemophilia A medications]] |
[[Category:Diffuse large B-cell lymphoma medications]] | [[Category:Diffuse large B-cell lymphoma medications]] | ||
[[Category:Erdheim-Chester disease medications]] | [[Category:Erdheim-Chester disease medications]] | ||
[[Category:Follicular lymphoma medications]] | [[Category:Follicular lymphoma medications]] | ||
[[Category:HIV-associated lymphoma medications]] | [[Category:HIV-associated lymphoma medications]] | ||
| − | [[Category:Hodgkin lymphoma medications]] | + | [[Category:Classical Hodgkin lymphoma medications]] |
[[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | [[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | ||
[[Category:Immune thrombocytopenia medications]] | [[Category:Immune thrombocytopenia medications]] | ||
| Line 204: | Line 206: | ||
[[Category:Transformed lymphoma medications]] | [[Category:Transformed lymphoma medications]] | ||
[[Category:Waldenström macroglobulinemia medications]] | [[Category:Waldenström macroglobulinemia medications]] | ||
| + | [[Category:Warm autoimmune hemolytic anemia medications]] | ||
[[Category:Breast cancer medications (historic)]] | [[Category:Breast cancer medications (historic)]] | ||
| − | [[Category:Chronic | + | [[Category:Chronic myeloid leukemia medications (historic)]] |
[[Category:Light-chain (AL) amyloidosis medications (historic)]] | [[Category:Light-chain (AL) amyloidosis medications (historic)]] | ||
[[Category:Medulloblastoma medications (historic)]] | [[Category:Medulloblastoma medications (historic)]] | ||
[[Category:FDA approved in 1955]] | [[Category:FDA approved in 1955]] | ||
| + | [[Category:EMA approved in 1955]] | ||
| + | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 19:27, 23 June 2024
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is established (work in progress)
- B-cell acute lymphoblastic leukemia
- Classical Hodgkin lymphoma
- Langerhans cell histiocytosis
- Multiple myeloma
- Non-Hodgkin lymphoma
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- Burkitt lymphoma
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- HIV-associated lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Non-Hodgkin lymphoma, pediatric
- Peripheral T-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Waldenström macroglobulinemia
- Prostate cancer
Diseases for which it is used
- Acquired hemophilia A
- B-cell lymphoma of mucosa-associated lymphoid tissue
- Chronic lymphocytic leukemia
- Erdheim-Chester disease
- High-grade glioma, pediatric
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Immune thrombocytopenia (ITP)
- Large granular lymphocytic leukemia
- Mediastinal gray-zone lymphoma
- Myelofibrosis
- Post-transplant lymphoproliferative disorder
- Smoldering multiple myeloma
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Warm autoimmune hemolytic anemia
Diseases for which it was used
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
History of changes in EMA indication
- 1955-05-18: EURD
Also known as
- Generic names: pred
- Brand names:
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| Artinizona | Artrizona | Becortem | Bersen | Colisone | Cortancyl | Corticorten | Cortigen |
| Cortiol | Cortiprex | Cutason | Dacortin | Decortancyl | Decortin | Decortisyl | Dehydrocortison |
| Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan | Deltacortene | Deltacortone | Deltason | Deltasone |
| Deltisona | Dispersona | Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten |
| Hostacortin | Ifison | Isolone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednisona | Prednisonum |
| Prednitone | Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison |
| Rayos | Rectodelt | Senterlic | Sone | Steerometz | Sterapred | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drugs
- Oral medications
- Immunosuppressants
- Steroids
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia medications
- Acquired hemophilia A medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Classical Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenia medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- MALT lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- Smoldering multiple myeloma medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- Warm autoimmune hemolytic anemia medications
- Breast cancer medications (historic)
- Chronic myeloid leukemia medications (historic)
- Light-chain (AL) amyloidosis medications (historic)
- Medulloblastoma medications (historic)
- FDA approved in 1955
- EMA approved in 1955
- WHO Essential Cancer Medicine